Method and apparatus for automatically evaluating the quality of the performance of a cardiac pacing system

• US 4,527,567 A
• Filed: 07/26/1982
• Issued: 07/09/1985
• Est. Priority Date: 04/01/1980
• Status: Expired due to Fees

• Current Assignee: Yeda Research and Development Co. Ltd. (Weizmann Institute of Science)
• Original Assignee: Yeda Research and Development Co. Ltd. (Weizmann Institute of Science)
• Inventors: Krupka, Yaakov, Fischler, Henryk, Behar, Salamon
• Primary Examiner(s): Kamm, William E.
• Application Number:
  US06/401,543
• Time in Patent Office: 1,079 Days
• Field of Search: 128/696, 128/697, 128/419 PT, 128/702-704, 128/708, 128/902
• US Class Current: 607/27
• CPC Class Codes: A61N 1/37 Monitoring; Protecting

Abstract

An extra-corporeal, self-contained, on-line, beat-to-beat pacemaker function analyzer (PFA) for automatic evaluation and indication of the quality of performance of cardiac pacing systems implanted in place for: routine examination of ambulatory patients; long-term surveillance of hospitalized patients; and examination of ECG traces (including pacing artefacts) of remote pacemaker patients, transferred by telephone or radio to a central follow-up station. The PFA provides a comprehensive examination of asynchronous, demand and demand-hysteresis pacemakers of all makes, including the state of the pacemaker'"'"'s battery, the intactness of the electronic circuitry and of the electrodes, and the proper location of the electrodes in the heart.

Claims

1. A method for automatically evaluating the quality of the performance of a cardiac pacing system including a human heart and an electronic pacemaker, said method operating in a beat-to-beat on-line manner, comprising the steps of:

continuously sensing the electrical pontentials appearing on the body surface of the human whose heart is part of the cardiac pacing system;

determining the presence of a pacing artifact in said electrical potentials by analyzing for the presence of an artifact peak and comparing said peak'"'"'s shape to the known shape of an artifact signal;

marking the appearance of each said pacing artifact by generating a pacing artifact determinant pulse signal defined in time and duration;

determining the presence in said electrical potentials of a QRS signal of either a spontaneous, paced separate or paced fused nature, including the steps of determining for the presence of a peak, comparing said peaks'"'"'s shape to the known shape of a spontaneous or paced separate QRS peak, analyzing the time interval between the QRS peak and the occurrence of the previous pacing artifact, and analyzing the integral of the electrical potentials throughout a predetermined time interval after the occurrence of a pacing artifact;

marking the appearance of each said QRS signal by generating a QRS determinant pulse signal defined in time and duration; and

evaluating the interrelation between the heart and the pacemaker and the quality of the pacemaker function by analyzing the interrelationship of said pacing artifact and QRS determinant pulses.

2. A method of accordance with claim 1, further including the steps of:

allowing analog, interference-free and noise-free processing of QRS signals of 0.25 to 2.5 mV in the presence of pacing artifact signals of 0.3 to 1,000 mV by amplifying both said QRS and pacing artifact signals by a gain of about 200 to a level of 50 to 500 mV for QRS and about 60 mV to 200 V for pacing artifacts; and

clipping said pacing artifact signals at a level of about 600 mV to preserve the information contained in both said QRS and said pacing artifact signals,

whereby undesirable effects in the electronic circuitry such as ringing, overshooting, oscillations and the like, which may be caused by high amplitude pacing artifact signals, are prevented.

3. A method in accordance with claim 1, wherein said step of determining the presence of a QRS signal includes analysing for the presence of a spontaneous QRS signal by determining the presence of a peak with consecutive rising and falling (or vice-versa) slopes of at least 10 mV/sec, each slope lasting for at least 9.5 msec, with the marked 9.5 msec ends of the slopes being parted from each other by a minimum of 15 msec and a maximum of 110 msec.

4. A method in accordance with claim 1, wherein said step of determining the presence of a QRS signal includes analyzing for the presence of a paced separate QRS signal by determining the presence of a peak with consecutive rising and falling (or vice-versa) slopes of at least 10 mV/sec, each slope lasting for at least 9.5 msec, with the marked 9.5 msec ends of the slopes being parted from each other by a minimum of 25 msec and a maximum of 120 msec, the beginning of the QRS signal following a pacing artifact by a minimum of 25 msec and a maximum of 185 msec.

5. A method in accordance with claim 1, wherein said step of determining the presence of a QRS signal includes analysing for the presence of a paced fused QRS signal by determining whether the integral of the electrical potential throughout a time interval between 25 and 50 msec after the occurrence of a pacing artifact, equals at least 14 mV msec.

6. A method in accordance with claim 1, wherein said step of determining the presence of a pacing artifact comprises determining whether the human is in tremor conditions, and determining the presence of a peak with consecutive rising and falling (or vice-versa) slopes of at least 2.6 V/sec, or 3.4 V/sec for a human in tremor conditions, the slopes being equal to each other within a difference of 20%, with the distance between the leading and trailing edges being between 0.4 msec and the nominal pacing pulse width of the particular pacemaker.

7. A method in accordance with claim 1, further including the steps of generating auxiliary signals simulating predetermined features of heart behavior including heart refractory span and pacing effectivity span, and wherein said evaluating step includes analysis of the interrelationship of all of said pacing artifact determinant pulses, QRS determinant pulses, heart refractory span signals and pacing effectivity span signals.

8. A method in accordance with claim 7, wherein said heart refractory span signal is generated 250 msec following a QRS signal and said pacing effectivity span signal is generated 185 msec following a pacing artifact signal.

9. A method in accordance with claim 1, wherein said sensing step is accomplished by means of an electrocardiograph, including electrode-to-body contacts, and wherein the method is accomplished by apparatus which includes a battery, and further including the step of constant self-checking of conditions serving as indicators of the state of the battery, satisfactory preparation of the electrode-to-body contacts and lack of spasm of underlying muscle, and lack of electrode movements, and providing an output when said conditions are unsatisfactory.

10. A method in accordance with claim 9, wherein said self-checking step includes determining whether the battery output voltage is below a predetermined lowest acceptable voltage, determining whether the noise is below an experimentally determined threshold, and determining whether the ECG biasline drifts beyond a predetermined amount.

11. A method in accordance with claim 9, wherein said evaluating step includes indicating a failure of the cardiac pacing system, and further including the steps of automatically signalling when said unsatisfactory condition output continues for a predetermined time, and instantly alarming in the event that said evaluating step determines that failure of the cardiac pacing system has occurred.

12. An apparatus for automatically evaluating the quality of the performance of a cardiac pacing system including a human heart and an electronic pacemaker, said apparatus operating in a beat-to-beat on-line manner, comprising:

means for continuously sensing the electrical potentials appearing on the body surface of the human whose heart is part of the cardiac pacing system;

means for determining the presence of a pacing artifact in said electrical potentials by analyzing for the presence of an artifact peak and comparing said peak'"'"'s shape to the known shape of an artifact signal;

means for marking the appearance of each said pacing artifact by generating a pacing artifact determinant pulse signal defined in time and duration;

means for determining the presence in said electrical potentials of a QRS signal of either a spontaneous, paced separate or paced fused nature, including means for determining for the presence of a peak, means for comparing said peak'"'"'s shape to the known shape of a spontaneous or paced separate QRS peak, means for analyzing the time interval between the QRS peak and the occurrence of the previous pacing artifact, and means for analyzing the integral of the electrial potential throughout a predetermined time interval after the occurrence of a pacing artifact;

means for marking the appearance of each said QRS signal by generating a QRS determinant pulse signal defined in time and duration; and

means for evaluating the interrelation between the heart and the pacemaker and the quality of the pacemaker function by analyzing the interrelationship of said pacing artifact and QRS determinant pulses.

13. An apparatus in accordance with claim 12, further including:

means for allowing analog, interference-free and noise-free processing of QRS signals of 0.25 to 2.5 mV in the presence of pacing artifact signals of 0.3 to 1,000 mV by amplifying both said QRS and pacing artifact signals by a gain of about 200 to a level of 50 to 500 mV for QRS and about 60 mV to 200 V for pacing artifacts; and

means for clipping said pacing artifact signals at a level of about 600 mV to preserve the information contained in both said QRS and said pacing artifact signals,

whereby undesirable effects in the electronic circuitry such as ringing, overshooting, oscillations and the like, which may be caused by high amplitude pacing artifact signals, are prevented.

14. An apparatus in accordance with claim 12, wherein said means for determining the presence of a QRS signal includes means for analysing for the presence of a spontaneous QRS signal by determining the presence of a peak with consecutive rising and falling (or vice-versa) slopes of at least 10 mV/sec, each slope lasting for at least 9.5 msec, with the marked 9.5 msec ends of the slopes being parted from each other by a minimum of 15 msec and a maximum of 110 msec.

15. An apparatus in accordance with claim 12, wherein said means for determining the presence of a QRS signal includes means for analysing for the presence of a paced separate QRS signal by determining the presence of a peak with consecutive rising and falling (or vice-versa) slopes of at least 10 mV/sec, each slope lasting for at least 9.5 msec, with the marked 9.5 msec ends of the slopes being parted from each other by a minimum of 25 msec and a maximum of 120 msec, the beginning of the QRS signal following a pacing artifact by a minimum of 25 msec and a maximum of 185 msec.

16. An apparatus in accordance with claim 12, wherein said means for determining the presence of a QRS signal includes means for analysing for the presence of a paced fused QRS signal by determining whether the integral of the electrical potential throughout a time interval between 25 and 50 msec after the occurrence of a pacing artifact, equals at least 14 mV msec.

17. An apparatus in accordance with claim 12, wherein said means for determining the presence of a pacing artifact comprises means for determining whether the human is in tremor conditions, and means for determining the presence of a peak with consecutive rising and falling (or vice-versa) slopes of at least 2.6 V/sec, or 3.4 V/sec for a human in tremor conditions, the slopes being equal to each other within a difference of 20%, with the distance between the leading and trailing edges being between 0.4 msec and the nominal pacing pulse width of the particular pacemaker.

18. An apparatus in accordance with claim 12, further including means for generating auxiliary signals simulating predetermined features of heart behavior including heart refractory span and pacing effectivity span, and wherein said means for evaluating the interrelationship between the heart and the pacemaker includes means for analysis of the interrelationship of all of said pacing artifact determinant pulses, QRS determinant pulses, heart refractory span signals and pacing effectivity span signals.

19. An apparatus in accordance with claim 18, wherein said means for generating auxiliary signals causes a heart refractory span signal to be generated 250 msec following a QRS signal and causes a pacing effectivity span signal to be generated 185 msec following a pacing artifact signal.

20. An apparatus in accordance with claim 12, wherein said means for sensing comprises an electrocardiograph, including electrode-to-body contacts, and further including a battery for driving the various means, means for constant self-checking of conditions serving as indicators of the state of the battery, satisfactory, preparation of the electrode-to-body contacts and lack of spasm of underlying muscle, and lack of electrode movements, and means for providing an output when said conditions are unsatisfactory.

21. An apparatus in accordance with claim 20, wherein said means for self-checking includes means for determining whether the battery output voltage is below a predetermined lowest acceptable voltage, means for determining whether the noise is below an experimentally determined threshold, and means for determining whether the ECG bias-line drifts beyond a predetermined amount.

22. An apparatus in accordance with claim 20, wherein said means for evaluating the interrelation between the heart and the pacemaker includes means for indicating a failure of the cardiac pacing system, and further including means for automatically signalling when said unsatisfactory condition output continues for a predetermined time, and means for instantly alarming in the even that said evaluating means determines that failure of the cardiac pacing system has occurred.